Get Diamond plan for FREE

    logo

    Agilon Health, Inc. (AGL)

    Price:

    0.50 USD

    ( + 0.11 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    AGL
    Name
    Agilon Health, Inc.
    Industry
    Medical - Care Facilities
    Sector
    Healthcare
    Price
    0.500
    Market Cap
    207.291M
    Enterprise value
    130.625M
    Currency
    USD
    Ceo
    Ronald Allan Williams
    Full Time Employees
    1076
    Ipo Date
    2021-04-15
    City
    Austin
    Address
    6210 East US Highway 290

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Universal Health Services, Inc.

    VALUE SCORE:

    8

    Symbol
    UHS
    Market Cap
    14.955B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare

    2nd position

    Encompass Health Corporation

    VALUE SCORE:

    10

    Symbol
    EHC
    Market Cap
    10.660B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare

    The best

    Chemed Corporation

    VALUE SCORE:

    11

    Symbol
    CHE
    Market Cap
    6.793B
    Industry
    Medical - Care Facilities
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -0.530
    P/S
    0.035
    P/B
    1.636
    Debt/Equity
    0.152
    EV/FCF
    -0.377
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.009
    Earnings yield
    -1.888
    Debt/assets
    0.015
    FUNDAMENTALS
    Net debt/ebidta
    0.417
    Interest coverage
    -144.355
    Research And Developement To Revenue
    0
    Intangile to total assets
    0.052
    Capex to operating cash flow
    -0.325
    Capex to revenue
    0.006
    Capex to depreciation
    1.201
    Return on tangible assets
    -0.325
    Debt to market cap
    0.093
    Piotroski Score
    4.000
    FUNDAMENTALS
    PEG
    0.020
    P/CF
    -1.960
    P/FCF
    -1.480
    RoA %
    -30.783
    RoIC %
    -215.674
    Gross Profit Margin %
    -1.294
    Quick Ratio
    1.019
    Current Ratio
    1.019
    Net Profit Margin %
    -6.597
    Net-Net
    -0.854
    FUNDAMENTALS PER SHARE
    FCF per share
    -0.338
    Revenue per share
    14.309
    Net income per share
    -0.944
    Operating cash flow per share
    -0.255
    Free cash flow per share
    -0.338
    Cash per share
    0.688
    Book value per share
    0.306
    Tangible book value per share
    0.147
    Shareholders equity per share
    0.306
    Interest debt per share
    0.054
    TECHNICAL
    52 weeks high
    6.080
    52 weeks low
    0.338
    Current trading session High
    0.526
    Current trading session Low
    0.393
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.664
    logo

    Country
    FR
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.407
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    -2.7298454%
    P/E
    -0.773
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -57.858
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -7.929
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.596
    logo

    Country
    HK
    Sector
    Healthcare
    Industry
    Medical - Care Facilities
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    414.662
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Equipment & Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.020
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -3.693
    logo

    Country
    CH
    Sector
    Healthcare
    Industry
    Medical - Healthcare Information Services
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -4.145
    DESCRIPTION

    agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

    NEWS
    https://images.financialmodelingprep.com/news/agilon-health-deadline-agl-investors-have-opportunity-to-lead-20260225.jpg
    Agilon Health Deadline: AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm

    prnewswire.com

    2026-02-25 16:54:00

    NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

    https://images.financialmodelingprep.com/news/agilon-deadline-rosen-a-topranked-law-firm-encourages-agilon-20260225.jpg
    AGILON DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AGL

    newsfilecorp.com

    2026-02-25 16:46:00

    New York, New York--(Newsfile Corp. - February 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

    https://images.financialmodelingprep.com/news/agilon-health-reports-fourth-quarter-and-full-year-fiscal-20260225.jpg
    agilon health Reports Fourth Quarter and Full Year Fiscal 2025 Results

    businesswire.com

    2026-02-25 16:05:00

    WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the fourth quarter and fiscal year ended December 31, 2025. “2025 was a pivotal year for agilon. We confronted challenges head-on and focused our actions to accelerate meaningful transformation across the company — enhancing execution, improving operating discipline, and fundamentally strengthening the economics o.

    https://images.financialmodelingprep.com/news/agilon-health-inc-agl-shareholders-who-lost-money-have-20260225.jpg
    agilon health, inc. (AGL) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

    prnewswire.com

    2026-02-25 12:00:00

    LOS ANGELES, Feb. 25, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company") (NYSE: AGL).

    https://images.financialmodelingprep.com/news/shareholders-of-agilon-health-inc-should-contact-levi-korsinsky-20260225.jpg
    Shareholders of agilon health, inc. Should Contact Levi & Korsinsky Before March 2, 2026 to Discuss Your Rights - AGL

    prnewswire.com

    2026-02-25 09:00:00

    NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc.

    https://images.financialmodelingprep.com/news/agl-upcoming-deadline-faruqi-faruqi-llp-reminds-agilon-health-20260224.jpg
    AGL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026

    newsfilecorp.com

    2026-02-24 20:48:00

    Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Agilon health To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - February 24, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Agilon health, inc.

    https://images.financialmodelingprep.com/news/agilon-deadline-march-2nd-bragar-eagel-squire-pc-urgently-20260224.jpg
    AGILON DEADLINE MARCH 2nd: Bragar Eagel & Squire, P.C. Urgently Reminds Agilon Health Investors with Larges Losses to Contact the Firm Before the Lead Plaintiff Deadline

    globenewswire.com

    2026-02-24 17:43:00

    Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options

    https://images.financialmodelingprep.com/news/investor-alert-pomerantz-law-firm-reminds-investors-with-losses-on-their-investment-in-agilon-20260224.jpg
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines - AGL

    globenewswire.com

    2026-02-24 16:52:00

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com  or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

    https://images.financialmodelingprep.com/news/agilon-deadline-rosen-the-first-filing-firm-encourages-agilon-20260224.jpg
    AGILON DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL

    globenewswire.com

    2026-02-24 15:06:00

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

    https://images.financialmodelingprep.com/news/bronstein-gewirtz-grossman-llc-urges-agilon-health-inc-investors-20260224.jpg
    Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm

    globenewswire.com

    2026-02-24 12:00:00

    New class action for agilon (AGL) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of Mar. 2, 2026.

    https://images.financialmodelingprep.com/news/portnoy-law-firm-announces-class-action-on-behalf-of-20260224.jpg
    Portnoy Law Firm Announces Class Action on Behalf of agilon health, inc. Investors

    globenewswire.com

    2026-02-24 10:19:00

    LOS ANGELES, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises agilon health, inc, (“agilon” or the "Company") (NYSE: AGL) investors off a class action on behalf of investors that bought securities between February 26, 2025 and August 4, 2025, inclusive (the “Class Period”). agilon investors have until March 2, 2026 to file a lead plaintiff motion.

    https://images.financialmodelingprep.com/news/the-gross-law-firm-reminds-shareholders-of-a-lead-plaintiff-deadline-of-20260224.jpg
    The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 2, 2026 in agilon health, inc. Lawsuit - AGL

    prnewswire.com

    2026-02-24 09:00:00

    NEW YORK, Feb. 24, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of agilon health, inc. (NYSE: AGL).

    https://images.financialmodelingprep.com/news/shareholder-alert-bernstein-liebhard-llp-announces-a-securities-fraud-class-action-lawsuit-has-been-filed-against-agilon-20260224.jpg
    SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against agilon health, inc. (NYSE: AGL)

    globenewswire.com

    2026-02-24 08:24:00

    Agilon Health Shareholders Between February 26, 2025 and August 4, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit

    https://images.financialmodelingprep.com/news/agl-investor-deadline-approaching-faruqi-faruqi-llp-reminds-agilon-20260223.jpg
    AGL INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds agilon health (AGL) Investors of Securities Class Action Deadline on March 2, 2026

    newsfilecorp.com

    2026-02-23 19:19:00

    Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - February 23, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc.

    https://images.financialmodelingprep.com/news/agilon-deadline-rosen-leading-investor-counsel-encourages-agilon-health-20260223.jpg
    AGILON DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AGL

    newsfilecorp.com

    2026-02-23 16:14:00

    New York, New York--(Newsfile Corp. - February 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

    https://images.financialmodelingprep.com/news/levi-korsinsky-reminds-agilon-health-inc-investors-of-the-20260223.jpg
    Levi & Korsinsky Reminds agilon health, inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 2, 2026 – AGL

    globenewswire.com

    2026-02-23 16:11:00

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit.